NCT01363024View on ClinicalTrials.gov

Trial Evaluating the Safety and Pharmacokinetics of MFGR1877S in Patients With Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

March 31, 2013

Study Completion Date

March 31, 2013

Conditions
Solid Tumor
Interventions
DRUG

MFGR1877S

Intravenous escalating dose

Trial Locations (5)

37203

Nashville

60637

Chicago

80045

Aurora

85258

Scottsdale

90404

Santa Monica

Sponsors

Lead Sponsor

Genentech, Inc.
All Listed Sponsors
lead

Genentech, Inc.

INDUSTRY